Skip to content
healthcare.dev

BEIZRAY

NDC 70710-2092, Docetaxel, injection, solution, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-2092
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218711
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2092 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOCETAXEL ANHYDROUS20 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
70710-2092-8707102092081 VIAL, GLASS in 1 CARTON (70710-2092-8) / 1 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8fb7d980-d6c7-468b-a9f0-adff16101a4b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70710-2092

Use it

Look up 70710-2092 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2092 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-2092. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.